New Drug Product: Imbruvica

Treatment of patients with mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.

Depression in Cancer Patients

Patients with cancer and depression frequently do not receive effective treatment.

Diabetes Risk for Lymphoma Survivors

Para-aortic radiation correlates with increased diabetes mellitus risk for Hodgkin's lymphoma survivors.

Colonic Diverticular Disease, Cancer

Colonic diverticular disease does not appear to be linked to an increased risk of subsequent colorectal cancer.

Botulinum Toxin as Cancer Treatment?

The therapeutic effects of systemic chemotherapy were enhanced by vagotomy or botulinum toxin type A treatment in a study.

Active Surveillance for Testicular Cancer

Active surveillance for clinical stage I (CSI) testis cancer leads to excellent outcomes.

NSAIDs, Breast Cancer Recurrence

Daily use of NSAIDs may reduce the recurrence rate of hormone-responsive breast cancer in overweight or obese women.

Prostate Cancer Treatments

Review this new chart on FDA-approved prostate cancer treatments for quick information when you need it.

News

Watchful Waiting May Not Be Best for All Men With Prostate Cancer

Watchful Waiting May Not Be Best for All Men With Prostate Cancer

Watchful waiting may not be suitable for all men with early-stage prostate cancer, especially black patients, according to new research.

Lung Cancer CT Screening in Older Patients Supported

Lung Cancer CT Screening in Older Patients Supported

Individuals aged 65-74 years with a history of smoking should not be excluded from screening with low-dose computed tomography (LDCT) for lung cancer.

How Staff Members View Dignified Death in Cancer Centers

How Staff Members View Dignified Death in Cancer Centers

About half of cancer center staff members perceive that a dignified death is possible for cancer patients on their wards.

Factors ID'd for CRC Risk Stratification With Positive FIT

Factors ID'd for CRC Risk Stratification With Positive FIT

Fecal hemoglobin concentration, sex, and age can be used to classify the risk of advanced colorectal neoplasia among individuals with positive results from fecal immunochemical tests (FITs).

Xtandi Approved for Metastatic Castration-Resistant Prostate Cancer

Xtandi Approved for Metastatic Castration-Resistant Prostate Cancer

Astellas and Medivation announced that the Food and Drug Administration has approved a new indication for Xtandi (enzalutamide) capsules for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC).

Charts

Make prescribing decisions with our comparative charts and treatment algorithms.

Calculators

Quickly and accurately perform clinical calculations.

Patient Information Fact Sheets

Download or print easy-to-read disease leaflets for your patients.

Featured courses from mycme

The Brigham Board Review in Hematology and OncologyExternal web site

The Brigham Board Review in Hematology and Oncology offers expert preparation for your ABIM subspecialty ...

CME 42.00 Credits

Understanding Current and Emerging Therapies for Head and Neck CancersExternal web site

This activity can help oncology nurses refresh their knowledge of the risks and treatments for ...

CE 0.50 Credits

Vertebroplasty is effective for managing myelomatous VCFsExternal web site

Nurse awareness of this treatment option and the patient selection criteria may be a significant ...

CE 0.60 Credits

Sign Up for Free e-newsletters